TCL Archive Anti-Nausea Drug Successful In Phase III Trial in Highly Emetogenic Chemotherapy May 30, 2014
TCL Archive FDA Advisors Uphold Broad Mandate To Limit Use Of ESA Products In Cancer Indications. May 11, 2007
TCL Archive In Brief: ACS to Spend Record $85 Million On Research: AACR To Honor Hanafusa, DeVita, Barbacid March 14, 1986